Abstract
Idiopathic dilated cardiomyopathy (DCM) is one of the fatal heart diseases which severely compromises cardiac performance. Various aspects of this disease have been analyzed and reported (1–7) including the pathophysiology, hemodynamics, and mortality, but many problems remain unresolved. One problem is that this disease is extremely resistant to therapy and no cardiotonic agent has been reported to decrease its mortality (8–11).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tanganelli P, Lenarda A, Bianciardi G, et al. Correlation between histomor-phometric findings on endomyocardial biopsy and clinical findings in idiopathic dilated cardiomyopathy. Am J Cardiol 64:504–506, 1989.
Figulla, H.R., Rahlf, G., Nieger, M., Luig, H., Kreuzer, H. Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation 71:1095–1104 1985.
Douglas, P.S., Morrow, R., Ioli, A., Reichek, N. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 13:311–315, 1989.
Juilliere, Y., Danchin, N., Briancon, S., et al. Dilated cardiomyopathy: long-term follow-up and predictors of survival. Int J Cardiol 21:269–277, 1988.
Katz, A.M. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 73(suppl III):III-184-190, 1986.
Hasenfuss, G., Holubarsch, C., Heiss, H.W., et al. Myocardial energetics in patients with dilated cardiomyopathy. Circulation 80:51–64, 1989.
Caforio, A.L.P., Stewart, J.T., McKenna, W.T. Idiopathic dilated cardiomyopathy. Rational treatment awaits better understanding of pathogenesis. Br Med J 300:890–891, 1990.
Shah, P.K., Amin, D.K., Hulse, S., Shellock, F., Swan, H.J.C. Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17, 043): Poor long-term results despite early hemodynamic and clinical improvement. Circulation 71:326–331, 1985.
Beber, K.T., Janicki, J.S., Jain, M.C. Enoximone(MDL-17, 043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy. Am J Cardiol 58:589–595, 1986.
Webster, M.W.I., Sarpe, D.N. Adverse effects associated with newer inotropic agents. Med Toxicol 1:335–342, 1986.
Packer, M., Medina, N., Yushak, M. Hemodynamic and clinical limitations of long-term inotropic therapy with Amrinone in patients with severe chrome heart failure. Circulation 70:1038–1047, 1984.
Suga, H., Igarashi, Y., Yamada, O., Goto, Y. Mechanical efficiency of the left ventricle as a function of preload, afterload, and contractility. Heart Vessels 1:3–8, 1985.
Suga, H., Hayashi, T., Shirahata, M. Ventricular systolic pressure-volume area as a predictor of cardiac oxygen consumption. Am J Physiol 240:H39–H44, 1981.
Suga, H., Hisano, R., Goto, Y., Yamada, O., Igarashi, Y. Effect of positive inotropic agents on the relation between oxygen consumption and pressure volume area in canine left ventricle. Circ Res 53:306–318, 1983.
Suga, H., Yasumura, Y., Nozawa, T., Futaki, S., Igarashi, Y., Goto, Y. Prospective prediction of O2 consumption from pressure-volume area in dog hearts. Am J Physiol 252:H1258–1264, 1987.
Suga, H. Total mechanical energy of a ventricle model and cardiac oxygen consumption. Am J Physiol 236:H498–H505, 1979.
Suga, H., Sagawa, K., Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 32:314–322, 1973.
Sunagawa, K., Maughan, W.L., Burkhoff, D., Sagawa, K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 245:H773–H780, 1983.
Sunagawa, K., Maughan, W.L., Sagawa, K. Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 56:586–595, 1985.
Report of the WHO/ISFC Task Force on the Definition and Classification of Cardiomyopathies. Br Heart J 44:672–673, 1980.
Goodwin, J.F. The frontiers of cardiomyopathy. Br Heart J 48:1–18, 1982.
Baan, J., van der Velde, E.T., de Bruin, H.G., et al. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70:812–823, 1984.
Dodge, H.T., Sandler, H., Baxley, W.A., Hawley, R.R. Usefulness and limitations of radiographic methods for determining left ventricular volume. Am J Cardiol 18:10–24, 1966.
Ishihara, H., Yokota, M., Sobue, T., Saito, H. Relation between ventriculoarterial coupling and myocardial energetics in patients with idiopathic cardiomyopathy. J Am Coll Cardiol 23:406–416, 1994.
Ganz, W., Tamura, K., Marcus, H.S., Donoso, R., Yoshida, S., Swan, H.J.C. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 4:181–195, 1971.
Maruyama, M., Kamiya, J., Kaiho, T., Kobari, T. Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts. J Cardiovasc Pharmacol 12:579–586, 1988.
Kamiya, J., Maruyama, M., Kaiho, T., Kobari, T. Characterization of MS-857, a new and potent cardiotonic agent, in isolated mammalian cardiac muscles. J Cardiovasc Pharmacol 14:790–797, 1989.
Nozawa, T., Yasumura, Y., Futaki, S., Tanaka, N., Uenishi, M., Suga, H. Efficiency of energy transfer from pressure-volume area to external mechanical work increases with contractile state and decreases with afterload in the left ventricle of the anesthetized closed-chest dog. Circulation 77:1116–1124, 1988.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yokota, M., Ishihara, H., Sobue, T. (1995). Effects of Various Inotropic Agents on the Relation Between Ventriculoarterial Coupling and Myocardial Energetics in Patients with Idiopathic Dilated Cardiomyopathy. In: LeWinter, M.M., Suga, H., Watkins, M.W. (eds) Cardiac Energetics: From Emax to Pressure-Volume Area. Developments in Cardiovascular Medicine, vol 177. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2021-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2021-4_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5836-7
Online ISBN: 978-1-4615-2021-4
eBook Packages: Springer Book Archive